Answers are grounded in this paper and cite their sources.
Review highlights pathogenic roles of mitochondria-associated membranes in cardiovascular diseases, suggesting novel therapeutic targets.
Abnormal function of suborganelles such as mitochondria and endoplasmic reticulum often leads to abnormal function of cardiomyocytes or vascular endothelial cells and cardiovascular disease (CVD). Mitochondria‐associated membrane (MAM) is involved in several important cellular functions. Increasing evidence shows that MAM is involved in the pathogenesis of CVD. MAM mediates multiple cellular processes, including calcium homeostasis regulation, lipid metabolism, unfolded protein response, ROS, mitochondrial dynamics, autophagy, apoptosis, and inflammation, which are key risk factors for CVD. In this review, we discuss the structure of MAM and MAM‐associated proteins, their role in CVD progression, and the potential use of MAM as the therapeutic targets for CVD treatment.
No takes yet. Share an insight, caveat, or question.
Luan et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: